Exscientia plc (EXAI)

$5.56

-0.17 (-2.97%)
Rating:
Recommendation:
-
Symbol EXAI
Price $5.56
Beta 0.000
Volume Avg. 0.15M
Market Cap 683.202M
Shares () -
52 Week Range 5.351-24.99
1y Target Est -
DCF Unlevered EXAI DCF ->
DCF Levered EXAI LDCF ->
ROE -
ROA -
Operating Margin -
Debt / Equity -
P/E -4.19 Strong Sell
P/B -
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest EXAI news


Healthcare
Biotechnology
NASDAQ Global Select

Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.